Organic Synthesis and Asymmetry

A special issue of Symmetry (ISSN 2073-8994). This special issue belongs to the section "Chemistry: Symmetry/Asymmetry".

Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 2870

Special Issue Editor


E-Mail Website
Guest Editor
Peptide Chemistry Science Technology Platform, Francis Crick Institute, London NW1 1AT, UK
Interests: organic synthesis; caged compounds; drug discovery; biologically active molecules

Special Issue Information

Dear Colleagues,

I have been engaged for many years in the synthesis and photochemical evaluation of photosensitive ‘caged’ compounds as tools for neurophysiological investigations. I have also been involved in the synthesis and application of chemical ligation auxiliaries for their effectiveness in solid-phase peptide synthesis. The scope of the work was not only to develop new technologies but also to improve existing tools for the synthesis of biologically useful proteins and other biomolecules. More recently my research has been focused in the design and synthesis of a variety of small molecules as tools for biomedical research, ranging from modified amino acids, heterocyclic compounds, labelled nucleosides, fluorescent probes for use as enzyme inhibitors or detectors, or as cross linkers in structural studies. Particularly synthesis of inhibitory compounds with potential to be developed as new types of antimalarial drugs or to study the role of Wnt signaling in tissue homeostasis or to study how the Wnt pathway is regulated in intestinal stem cell and cancer.

Please note that all submitted papers must be within the general scope of the Symmetry journal.

Dr. George Papageorgiou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Symmetry is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • photolabile biomolecules
  • chemical ligation auxiliaries
  • biosensor synthesis
  • neuroactive amino acids and peptides
  • new antimalarial and cancer drugs

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 2343 KiB  
Article
Density Functional Theory Studies and Molecular Docking on Xanthohumol, 8-Prenylnaringenin and Their Symmetric Substitute Diethanolamine Derivatives as Inhibitors for Colon Cancer-Related Proteins
by Manos C. Vlasiou, Christos C. Petrou, Yiannis Sarigiannis and Kyriaki S. Pafiti
Symmetry 2021, 13(6), 948; https://0-doi-org.brum.beds.ac.uk/10.3390/sym13060948 - 26 May 2021
Cited by 5 | Viewed by 2547
Abstract
Diethanolamine is a tridentate symmetric ligand that is used for organic synthesis to increase metal chelation or alter the molecular polarities. Prenylated flavonoids are well known for their anticancer properties even in colon cancer. Colorectal cancer is a major threat to society causing [...] Read more.
Diethanolamine is a tridentate symmetric ligand that is used for organic synthesis to increase metal chelation or alter the molecular polarities. Prenylated flavonoids are well known for their anticancer properties even in colon cancer. Colorectal cancer is a major threat to society causing death through metastasis to several patients with stage IV. Here, we provided altered structures of xanthohumol and 8-prenylanaringenin of the symmetric ligand diethanolamine, based on theoretical studies that are showing better binding affinities to several colon cancer-related proteins. Using molecular docking and dynamics, alongside density function theory and ADMET studies we are representing these two new derivatives of prenylated flavonoids having promising results against this disease. Full article
(This article belongs to the Special Issue Organic Synthesis and Asymmetry)
Show Figures

Figure 1

Back to TopTop